The race to develop immunotherapies for canine lymphoma and osteosarcomaJanuary 2, 2019There are many reasons why development of immunotherapies in dogs has been slow. Although cancer, and in particular lymphoma and osteosarcoma, is frequent in dogs, just one percent of owners have pet insurance; those who don’t are willing to spend only a limited amount of money to treat their dog, especially when initial treatment results are not as dramatic as in humans.
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More
Zomedica partners with IncellDx to help fight canine and human cancerDecember 21, 2018An assay agreement between two companies has been made to identify and enumerate circulating tumor cells (CTCs) from canine cancers.
"Nutrition Essentials" e-book available for free downloadDecember 6, 2018Nutrition Essentials is a four-part e-book exploring the role of nutrition in keeping dogs and cats healthy in the areas of chronic kidney disease, dermatology, obesity, and oncology.
Cancer tech's futureNovember 22, 2018Veterinary oncology imaging has evolved greatly over the past decade, allowing for earlier detection, improved treatment, and more successful outcomes. Veterinary Practice News reached out to three prominent veterinary oncology centers around the U.S. to discuss imaging equipment, promising research, and what the future holds in this important field.
TVMA advises pets undergo annual wellness exams to detect cancer earlyNovember 12, 2018It's National Pet Cancer Awareness Month and the Texas Veterinary Medical Association (TVMA) is urging veterinarians and pet owners to practice annual wellness exams in order to address preventative diseases and detect the early stages cancer.
Nutrition's role in cancer patientsNovember 5, 2018Nutrition is always important in helping a sick pet get better, and it can be an essential element of care for cancer patients and for pets recovering from debilitating illnesses or surgery. Cancer and its treatments may alter the body’s ability to tolerate particular foods or use certain nutrients; moreover, clients often have a firm belief in nutrition as good medicine and may ask about or even insist on special diets or supplements for pets undergoing cancer treatments or otherwise in need of tender loving care.
Clinical trial shows possible longer life for dogs with osteosarcomaNovember 1, 2018Fifteen dogs diagnosed with osteosarcoma survived a median time of 415 days after completing canine osteosarcoma immunotherapy, according to a clinical trial by ELIAS Animal Health.
Is cancer increasing in cats and dogs?October 2, 2018I often see claims in the media—from veterinarians as well as lay people—that canine and feline cancer rates are rising, and we are experiencing an “epidemic.” Usually, this is a prelude to further claims about the causes of this so-called epidemic. Finally, a solution is typically offered, involving either eschewing the purported causes of cancer or employing a diet, supplement, “detox” program, or some other product or method recommended (and sold) by whomever is making the claims.
Torigen Pharma wins 2018 KC Animal Health Corridor Innovation AwardAugust 30, 2018Torigen Pharmaceuticals Inc., a Farmington, Conn., company that provides personalized cancer immunotherapies to the veterinary market, has won the Innovation Award at the KC Animal Health Corridor Investment Forum in Kansas City, Mo. Torigen presented its autologous immunotherapeutic cancer vaccine, VVax-001, for dogs during the forum. The company was honored with the award and a check for $10,000. Torigen was among 12 emerging animal health companies from three countries who competed for investments in a "Shark Tank" format with more than 400 venture capital funds, investment firms, and potential partners at the 10th annual KC Animal Health Investment Forum on Aug. 21. Each company was given 10 minutes to present their ideas followed by a five-minute Q&A. Presenting companies were seeking anywhere from $500,000 to $20 million in funding and had revenue projections of $20 million within five to seven years. A national committee of agricultural and animal health experts selected the finalists. The Investment Forum in Kansas City is one of the world's only opportunities for early-and mid-stage animal health entrepreneurs to present their business plans and provide an inside look at the newest technology and innovations to potential investors. "The Global Animal Health Investment Forum is the …
OSU enrolling dogs with mammary cancer for clinical trialAugust 29, 2018Oregon State University's Lois Bates Acheson Veterinary Teaching Hospital is now enrolling dogs with mammary cancer in a new clinical trial. Dog owners considering standard tumor removal surgery may be able to choose a new surgical procedure involving an intravenous injection of a cancer cell-illuminating nanoparticle compound that highlights exactly which tissue needs to be removed. After the mammary tumor is removed, the surrounding tissue is irradiated with an infrared laser that causes the nanoparticle compound to heat up, killing any remaining cancer cells. The compound, developed by researchers in the Oregon State University College of Pharmacy, has been found to effectively cure cancer in mice. The new procedure eventually may be most beneficial for treating tumors in challenging anatomic areas, such as the brain and spine, according to Milan Milovancev, DVM, DACVS-SA, an OSU associate professor of small animal surgery participating in the study. The Oregon State University Carlson College of Veterinary Medicine is a member of a national consortium of veterinary oncology centers, managed by the National Institutes of Health, with a focus on translational veterinary medicine. Owners who believe their pets may be good trial candidates can ask their veterinarian …
